MedPath
HSA Approval

NARCARICIN MITE TABLET 50 mg

SIN06371P

NARCARICIN MITE TABLET 50 mg

NARCARICIN MITE TABLET 50 mg

July 3, 1991

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

M04AB03

benzbromarone

Manufacturer Information

APOTHECA MARKETING PTE LTD

EXCELLA GMBH & Co. KG

Active Ingredients

BENZBROMARONE

50 mg

Benzbromarone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.